id: NEW:nafld_prevalence_to_all_cause_mortality_rate
name: Non-alcoholic fatty liver disease prevalence â†’ All-cause mortality rate
from_node:
  node_id: NEW:nafld_prevalence
  node_name: Non-alcoholic fatty liver disease prevalence
to_node:
  node_id: all_cause_mortality_rate
  node_name: All-cause mortality rate
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: NAFLD involves hepatic steatosis and progressive liver inflammation, leading
  to non-alcoholic steatohepatitis (NASH) in a subset of patients'
- 'Step 2: Progressive liver damage leads to fibrosis, cirrhosis, and increased risk
  of hepatocellular carcinoma (1.8 cases per 1000 person-years)'
- 'Step 3: NAFLD is associated with systemic metabolic dysfunction including insulin
  resistance, dyslipidemia, and chronic inflammation'
- 'Step 4: These metabolic derangements increase cardiovascular disease risk, which
  is a leading cause of death in NAFLD patients'
- 'Step 5: Combined hepatic and cardiovascular complications result in elevated overall
  mortality rate (5.3 deaths per 1000 person-years)'
evidence:
  quality_rating: A
  n_studies: 237
  primary_citation: 'Jie Li et al. 2019. Prevalence, incidence, and outcome of non-alcoholic
    fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.
    The lancet. Gastroenterology & hepatology.'
  supporting_citations: []
description: Non-alcoholic fatty liver disease (NAFLD) is associated with increased
  all-cause mortality through multiple pathways including progressive liver disease
  leading to cirrhosis and hepatocellular carcinoma, as well as systemic metabolic
  dysfunction contributing to cardiovascular mortality. This meta-analysis of 237
  studies across Asia found an overall mortality rate of 5.3 deaths per 1000 person-years
  among NAFLD patients, with hepatocellular carcinoma incidence of 1.8 cases per 1000
  person-years.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 5.3
    type: incidence_rate
    ci_lower: 1.5
    ci_upper: 11.4
  p_value: null
  sample_size: 13044518
moderators:
- name: age
  direction: strengthens
  strength: moderate
  description: Older individuals identified as high-risk group for NAFLD complications
    and mortality
- name: sex
  direction: strengthens
  strength: moderate
  description: Men identified as higher risk group for NAFLD-related outcomes
- name: obesity
  direction: strengthens
  strength: strong
  description: Obese individuals identified as high-risk group for NAFLD complications
    and mortality
- name: time_period
  direction: strengthens
  strength: moderate
  description: NAFLD prevalence has increased significantly over time, suggesting
    growing disease burden
